Efficacy and safety of glucose-lowering agents in patients with type 2 diabetes: A network meta-analysis of randomized, active comparator-controlled trials
Author:
Funder
Merck
Novartis
Bristol-Myers Squibb
Boehringer Ingelheim
Publisher
Elsevier BV
Subject
Cardiology and Cardiovascular Medicine,Nutrition and Dietetics,Endocrinology, Diabetes and Metabolism,Medicine (miscellaneous)
Reference31 articles.
1. Network meta-analysis of nine large cardiovascular outcome trials of new antidiabetic drugs;Alfayez;Prim Care Diabetes,2019
2. Comparison of new glucose-lowering drugs on risk of heart failure in type 2 diabetes: a network meta-analysis;Kramer;JACC Heart Fail,2018
3. Cardiovascular outcomes in trials of new antidiabetic drug classes: a network meta-analysis;Fei;Cardiovasc Diabetol,2019
4. Association between use of sodium-glucose cotransporter 2 inhibitors, glucagon-like peptide 1 agonists, and dipeptidyl peptidase 4 inhibitors with all-cause mortality in patients with type 2 diabetes: a systematic review and meta-analysis;Zheng;JAMA,2018
5. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group;Lancet,1998
Cited by 11 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Glucagon-like Peptide 1 Receptor Agonists and Cardiovascular Outcomes in Solid Organ Transplant Recipients With Diabetes Mellitus;Transplantation;2024-02-16
2. Metabolic bariatric surgery as a therapeutic option for patients with type 2 diabetes: A meta‐analysis and network meta‐analysis of randomized controlled trials;Diabetes, Obesity and Metabolism;2023-06-05
3. 2023 update on Italian guidelines for the treatment of type 2 diabetes;Acta Diabetologica;2023-05-26
4. Diabetes Mellitus;Practical Issues in Geriatrics;2023
5. Italian guidelines for the treatment of type 2 diabetes;Nutrition, Metabolism and Cardiovascular Diseases;2022-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3